Evidence map›Paper›PMID 35308024›Full record

ReviewRSC medicinal chemistry2022

Antibacterial activities of plant-derived xanthones.

Xiaojia Liu, Jianzhong Shen, Kui Zhu

Open access · greenAbstract readReview
In one paragraph

Review in RSC medicinal chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Synthesis, characterization,RSC advances · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Plants (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Antimicrobial activity of α-mangostin againstFrontiers in cellular and infection microbiology · 2023
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Xiaojia LiuNational Center for Veterinary Drug Safety Evaluation, College of Veterinary Medicine, China Agricultural University Beijing 00193 China liuxj@cau.edu.cn.ORCID https://orcid.org/0000-0002-7375-8993
Jianzhong ShenNational Center for Veterinary Drug Safety Evaluation, College of Veterinary Medicine, China Agricultural University Beijing 00193 China liuxj@cau.edu.cn.ORCID https://orcid.org/0000-0002-8502-8445
Kui ZhuNational Center for Veterinary Drug Safety Evaluation, College of Veterinary Medicine, China Agricultural University Beijing 00193 China liuxj@cau.edu.cn.ORCID https://orcid.org/0000-0001-8242-3952
China Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing threat to global health posed by antibiotic resistance remains a serious concern. This troublesome scenario has steered a need for the discovery and evaluation of novel antibacterial agents. Natural products are the main sources of antimicrobials used in clinical practice, serving as a rich reservoir for the discovery of new antibiotics. Pharmaceutical phenolics especially xanthones widely exist in the plant kingdom, and are important plant metabolites. They possess versatile biological activities, including antiviral, antibacterial, neurotrophic, and anticancer. In the present study, we focus on the antibacterial activities of phytoxanthones and summarize their structures and sources, categories and drug-likeness evaluations, and antibacterial activities. A total of 226 different plant xanthones are identified through the NETs screening, and most of them are distributed in

Identifiers

PMID35308024
PMCPMC8864485
OpenAlexW4200010506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.